About This Publication:

  • Print This Page
  • Text a Friend
  • Subscribe to an RSS Feed

Sample Content 

My Liebert Connect

Sign up to stay informed--receive email notifications for this journal

Genetic Testing and Molecular Biomarkers

Editor-in-Chief: Kenneth I. Berns, MD, PhD

ISSN: 1945-0265 • Published Monthly • Online ISSN: 1945-0257

Current Volume: 18

Latest Impact Factor* is 1.147

*2013 Journal Citation Reports® published by Thomson Reuters, 2014

A dynamic new author services platform
to share, measure, and enhance the impact of your research
Complimentary one-year membership with submission to this journal

For Authors

  • Manuscript Submissions
  • NIH/HHMI Wellcome Trust Policies
  • Self-Archiving Policy
  • Open Access Policy
  • Manuscript Submissions

    Genetic Testing and Molecular Biomarkers publishes original papers on all aspects of human genetic testing, including prenatal diagnosis, risk assessment, clinical consequences of molecular genetics, results of population screens and targeted testing, methodologies, strategies and ethical and legal issues.

    Mary Ann Liebert, Inc. Submission Benefits Package

    Your submission to Genetic Testing and Molecular Biomarkers provides you with robust tools and support to ensure maximum impact and readership for your work. By submitting your manuscript, you’ll receive:

    • Complimentary 12-month AuthorCite® membership
      Exclusively licensed by Mary Ann Liebert, Inc., AuthorCite® delivers a 360-degree view of your article from submission to publication to market impact. With an AuthorCite® membership, you’ll receive end-to-end manuscript submission tracking, a custom online microsite to promote you and your research, a professional suite of metrics and analytics to measure the impact of your article, 30-day OpenLink™ article sharing, and much more.
    • Rapid, rigorous peer-review and editorial attention
    • Immediate deposit to PubMed and other indexing services upon online publication
    • Exposure to thousands of thought-leaders in your field, maximizing readers,citations, and downloads
    • Fast Track online-ahead-of-print publication
    • Global availability in over 170 countries
    • Open Access publication options


    Submitting your manuscript to Genetic Testing and Molecular Biomarkers delivers a comprehensive benefits program that ensures high-quality review of your research and maximum impact for your work. This includes a one-year membership to AuthorCite™, a robust author services platform for increasing the visibility of your research, and includes the ability to freely share your article for 30 daysGenetic Testing and Molecular Biomarkers carries a manuscript processing charge* of $49 USD upon submission of each new manuscript.

    Upon payment, you will be provided a Manuscript Submission Code, and will be prompted to enter this information when uploading your files to our peer-review system.  Please note:  Securing a token does not automatically create an account in our peer-review system. If you do not already have an account, you will be asked to create one before you can begin your submission.

    Submissions do not need to be completed at once. Submitting authors/agents may begin the submission process, save their work, and return to the site to complete the upload(s) at a later time. There is no limit on the number of times one can save their work and subsequently resume the submission. Doing so will not incur additional charges.

    Click here to submit your paper via our fast and user-friendly electronic submission system.


    Processing charges and submission codes are NOT required for revisions to previously submitted papers. To upload a revision of a paper, the submitting author should log in to their Author Center at  http://mc.manuscriptcentral.com/genetic-testing click on “Revised Manuscripts in Draft.” The paper will appear in this area, and the submitting author will be able to upload revised files without paying any charges or entering a submission code.

    Please be sure to follow the Instructions for Authors below on Manuscript Preparation.  Authors whose submissions do not comply with the Instructions for Authors will have their papers un-submitted so that the file(s) may be adjusted accordingly. Directions regarding the necessary corrective actions will be provided in an email to the corresponding author at the time the paper is un-submitted. The submitting author/agent will then be provided the opportunity to re-upload the corrected file(s). If a paper is un-submitted, the paper will reside in the corresponding author’s “Author Center” as a draft, and the submitting author/agent will be able to make the necessary adjustments and re-upload the paper without incurring another manuscript processing charge. 

    *The manuscript processing charge is independent of editorial decision and is non-refundable.



    Online submission of the manuscript is required, in either PC (preferred) or Macintosh format, preferably in Microsoft Word or Word Perfect.

    The manuscript should be double-spaced with a minimum 1.25 inch margin. On the first page, give the title of the paper, name(s) of the author(s), and institutional affiliations(s). Please also indicate the corresponding author and full contact information, including e-mail address, and supply a running title of about 45 characters. On the second page, supply an Abstract of about 200 words, stating the aims, results, and conclusions. Subsequent pages should provide the following in sequence: Introduction, Materials and Methods, Results, Discussion, Acknowledgments, References, tables, and figure legends. Number pages consecutively. The first author’s last name should appear on each page. A separate page should include the full mailing address and contact information (telephone, fax, and e-mail address) for each author listed on the title page. Authors should also include the names, affiliations, and e-mail addresses of at least 3 reviewers. Original articles should be limited to 3,000 words, and Review articles should not exceed 4,000 words. These word counts do NOT include the abstract, acknowledgment or disclosure sections, or the reference list.


    Prepare each table with its caption in a separate file. Use arabic numerals to number tables. Do not repeat information that is given in the text, and do not make a table for data that can be given in the text in one or two sentences.The Journal will publish color photographs, but the author will be charged for the cost of color  printing. The Publisher will provide the author with a more precise cost estimate when the figures are received. For further details, contact the Editor or Publisher. Please follow these guidelines for submitting figures:

    • Do NOT embed art files into a Word or PDF document. Figures provided in this format cannot be used for production purposes.

    • Line illustrations should be submitted at 600 dpi.

    • Halftones and color should be submitted at a minimum of 300 dpi.

    • Save as either TIFF or EPS files. JPEG files are for screen representation-quality only and will print very poorly during the printing process. To ensure proper print quality, please submit only TIFF or EPS files.

    • Color art must be saved as CYMK - not RGB. (NB: If RGB files are submitted, the files will be converted to CYMK and some color variation will occur.)

    • Black and white art must be submitted as grayscale – not RGB.

    • Do NOT submit PowerPoint, PDF, Bitmap or Excel figure or table files. When naming your figure and table files, please label them with the main author’s last name, followed by a period (.), and then list the figure number. Ex: Smith.Fig1; Smith.Table1. Label figures and tables inside the files in addition to naming the file with the figure or table number. (ie: When figures or table files are opened, the figure or table number should appear inside the file.)

    You will be given directions on how to correct any files which do not pass. 


    • A title page which includes the title of the paper, as well as ALL author’s names, affilliations, e-mail addresses, and contact information.

    • An abstract (uploading your abstract into the appropriate field in Manuscript Cental will NOT automatically incorporate it into the text file, so, please include the abstract within the manuscript file).

    • References section correctly formatted (see examples).

    • Tables and figures should be uploaded as individual files.

    • Do NOT upload a PDF of your text file.

    ADDITIONAL INFORMATION ABOUT ART FILES Converting Word or Excel files:

    Perhaps the best and easiest way to convert Word or Excel files into a format which is suitable for print is to scan them using the below guidelines:

    • All files should be scanned at 100% size.
    • 300 dpi
    • Final color mode: CMYK
    • save file as: .tif or .eps

    If you need directions on how to convert a Power Point slide to acceptable format go to http://www.liebertpub.com/MEDIA/pdf/ppconvert.pdf 

    Color publication of figures is encouraged, but the cost for color printing must be subsidized by the author(s). Color costs apply to all manuscripts, including those invited, unless the contributor has made prior arrangements with the Publisher. Alternatively, figures may be published in color in the online version of the journal, and black and white in the print version. This is an administrative cost and is instituted since two versions of the article must be prepared; one for print and one for online.

    Please consider these costs when preparing your manuscript for submission.  Contact publisher for color costs.


    Please upload individual files of all manuscript material—do NOT upload a single PDF file containing all text, figure, and table files of your paper. Once all individual files are uploaded on to Manuscript Central, the system will automatically create a single PDF proof for you and the peer-review process.


    Within the text, all references should be cited by authors and dates. Reference citations are not permitted in the abstract of a paper. If more than two authors are involved, use et al. after the first author’s name. If several papers by the same authors in the same year are cited in one sentence, use a lower case letter designation to indicate the individual papers—i.e. (Dunn and Studier, 1973a, 1973b). Use the same designation in the reference list. In the References section, each item should be double-spaced and listed in alphabetical order at the end of the paper. Each reference should include all authors’ names and the complete title of the cited paper. If more than three authors are involved, use et al. after the third author’s name. When data from an unpublished source are given, supply the researcher’s name. If the work is in press, give the journal in which it is to be published or the name of the publisher. Abbreviation of journal names should follow the style of MEDLINE.


    In the References list, citations should include all authors and the complete title in the following style (as in the American Journal of Human Genetics):

    Journal article:
    Lagoe E, LaBella S, Arnold G, et al. (2005) Cystic fibrosis newborn screening: A pilot study to maximize carrier screening. Genet Test 9:255–260.


    Peters DJM, Sandkuijl LA (1992) Genetic heterogeneity of polycystic kidney disease in Europe. In: Breuning MH, Devoto M, Romeo G (eds) Contributions to nephrology: Polycystic kidney disease. Karger, Basel, pp 128–139.


    Ministry of Health (2008) Guidelines for genetic testing before or during pregnancy. Available at www.health.gov.il/pages/default.asp?maincat¼42&catid¼217&pageid1696, accessed May 21 2008.


    Immediately following the Acknowledgments section, include a section entitled ‘‘Author Disclosure Statement.’’

    In this portion of the paper, authors must disclose any commercial associations that might create a conflict of interest in connection with submitted manuscripts. This statement should include appropriate information for EACH author, thereby representing that competing financial interests of all authors have been appropriately disclosed according to the policy of the Journal. It is important that all conflicts of interest, whether they are actual or potential, be disclosed. This information will remain confidential while the paper is being reviewed and will not influence the editorial decision.

    Please see the Uniform Requirements for Manuscripts Submitted to Biomedical Journals at http://www.icmje.org/index.html#conflicts for further guidance.

    If no conflicts exist, the authors must state ‘‘No competing financial interests exist.’’


    The author must obtain permission whenever it is required in conjunction with the reproduction of material such as figures and tables from copyrighted material. Written permission must be obtained from the publisher of the journal or book concerned. The publication from which the figure or table is taken must be listed in the reference list. Finally, a footnote of a reprinted table, or of the legend of a reprinted figure should read, “reprinted by permission from Jones et al.” and list the appropriate reference. All permissions listings must be shown in the manuscript—they cannot be entered on proofs. Manuscripts submitted to this Journal must not be under consideration elsewhere.


    Reprints may be ordered by following the special instructions that will accompany page proofs, and should be ordered at the time the corresponding author returns the corrected page proofs to the Publisher. Reprints ordered after an issue is printed will be charged at a substantially higher rate.


    Genetic Testing and Molecular Biomarkers is published by Mary Ann Liebert, Inc., 140 Huguenot Street, New Rochelle, NY 10801-5215. Telephone: (914) 740-2100; fax; (914) 740-2101; e-mail: info@liebertpub.com Internet: www.liebertpub.com

  • NIH/HHMI Wellcome Trust Policies

    NIH Public Access Policy: In order to assist our authors who have NIH funding to comply with this policy, Mary Ann Liebert, Inc. publishers will deposit the final accepted paper (after copy-editing and proofreading) to PubMed Central (PMC) on behalf of the authors. Authors need not take any action. The manuscript's public access posting on PMC will occur 12 months after final publication. This service is provided free of charge. Please note that authors may not deposit manuscripts directly to PMC or other sites without permission from Mary Ann Liebert, Inc.

  • Self-Archiving Policy

    Mary Ann Liebert, Inc. is a "blue" publisher (as defined by Sherpa), as we allow self-archiving of post-print (ie final draft post-refereeing) or publisher's version/PDF.

    In assigning Mary Ann Liebert, Inc. copyright, the author retains the right to deposit such a 'post-print' on their own website, or on their institution's intranet, or within the Institutional Repository of their institution or company of employment, on the following condition, and with the following acknowledgement:

    This is a copy of an article published in the [JOURNAL TITLE] © [year of publication] [copyright Mary Ann Liebert, Inc.]; [JOURNAL TITLE] is available online at: http://online.liebertpub.com.

    Authors may also deposit this version on his/her funder's or funder's designated repository at the funder's request or as a result of a legal obligation, provided it is not made publicly available until 12 months after official publication.

  • Open Access Policy

    Choose Liebert Open Access Option!

    Ensure maximum visibility, discoverability, and impact for your article with our Liebert Open Access (OA) Option.

    Your investment guarantees:

    • Immediate, unrestricted global access in 170 countries
    • Maximum visibility for increased readers, citations, and downloads
    • Targeted email announcement highlighting your article to thousands of thought-leaders in your field
    • Rapid, rigorous peer-review and editorial attention
    • Fast Track online-ahead-of-print publication
    • Immediate upload to PubMed Central and other internationally recognized repositories*
    • Recognition on online Table of Contents with exclusive OA icon
    • Compliance with OA funding mandates with no embargo period
    • Savings on future OA article publication
    • Complimentary membership in AuthorCite®, the author services platform exclusively licensed by Mary Ann Liebert, Inc. that delivers the tools you need to maximize your professional impact.

    These valuable benefits are included with a one-time article processing charge (APC). APC charge varies based on journal, membership, and subsequent submissions.

    Contact openaccess@liebertpub.com for questions on article Open Access options. 

     *Please note that PubMedCentral, not the Publisher, has sole control over when the paper is made live on PMC.


    Is your Institution a member of the Liebert Author Advocacy Program?

    The Liebert Author Advocacy Program (LAAP) provides valuable membership benefits for OA publication to institutional and funding organizations, and supports global funding mandates.  Authors who are affiliated with LAAP member institutions receive all the valuable benefits of Liebert OA article publication, and more.

    For details, and to recommend institutional membership visit: www.authoradvocacy.com or contact laap@liebertpub.com 




The views, opinions, findings, conclusions and recommendations set forth in any Journal article are solely those of the authors of those articles and do not necessarily reflect the views, policy or position of the Journal, its Publisher, its editorial staff or any affiliated Societies and should not be attributed to any of them.

Recommended Publications

You may be interested in the following publications:

    Human Gene Therapy

    Human Gene Therapy

    The definitive rapid-publication journal covering all aspects of gene therapy through original investigations into the transfer and expression of genes in mammals, with in-depth coverage of DNA, RNA, and cell therapies.

    DNA and Cell Biology

    DNA and Cell Biology

    Combining mechanistic and clinical studies from multiple systems in a single resource, the Journal delivers authoritative, peer-reviewed reporting on the latest research in the field of molecular biology.

    Controversies in Science and Technology Volume 2:
    From Climate to Chromosomes

    Controversies in Science and Technology Volume 2:
    From Climate to Chromosomes

    Explores five of the most controversial scientific issues facing our world today: stem cell research, information technology, space exploration, global warming, and biology and gender.

    Journal of Women's Health

    Journal of Women's Health

    The primary source of information for meeting the challenges of providing optimal healthcare for women throughout their lifespan.

Browse All Publications »